NZ595437A - Short-chain peptides as parathyroid hormone (pth) receptor agonist - Google Patents
Short-chain peptides as parathyroid hormone (pth) receptor agonistInfo
- Publication number
- NZ595437A NZ595437A NZ595437A NZ59543710A NZ595437A NZ 595437 A NZ595437 A NZ 595437A NZ 595437 A NZ595437 A NZ 595437A NZ 59543710 A NZ59543710 A NZ 59543710A NZ 595437 A NZ595437 A NZ 595437A
- Authority
- NZ
- New Zealand
- Prior art keywords
- receptor agonist
- parathyroid hormone
- pth
- short
- chain peptides
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000003982 Parathyroid hormone Human genes 0.000 title 1
- 108090000445 Parathyroid hormone Proteins 0.000 title 1
- 239000000199 parathyroid hormone Substances 0.000 title 1
- 229960001319 parathyroid hormone Drugs 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- 229940116372 Parathyroid hormone receptor agonist Drugs 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1095MU2009 | 2009-04-24 | ||
| IN225MU2010 | 2010-01-28 | ||
| PCT/IN2010/000264 WO2010128521A2 (en) | 2009-04-24 | 2010-04-26 | Short-chain peptides as parathyroid hormone (pth) receptor agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ595437A true NZ595437A (en) | 2014-03-28 |
Family
ID=43050579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ595437A NZ595437A (en) | 2009-04-24 | 2010-04-26 | Short-chain peptides as parathyroid hormone (pth) receptor agonist |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8383581B2 (enExample) |
| EP (1) | EP2421893A2 (enExample) |
| JP (1) | JP5744844B2 (enExample) |
| KR (1) | KR101451470B1 (enExample) |
| CN (1) | CN102405229A (enExample) |
| AU (1) | AU2010245642A1 (enExample) |
| BR (1) | BRPI1008103A2 (enExample) |
| CA (1) | CA2757874C (enExample) |
| EA (1) | EA022212B1 (enExample) |
| IL (1) | IL215625A (enExample) |
| MX (1) | MX2011010968A (enExample) |
| NZ (1) | NZ595437A (enExample) |
| SG (1) | SG174532A1 (enExample) |
| WO (1) | WO2010128521A2 (enExample) |
| ZA (1) | ZA201107078B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3928487A (en) * | 1974-11-27 | 1975-12-23 | Standard Oil Co | Alkylation process utilizing hydrofluoric acid with a minor amount of fluorosulfuric acid |
| UY32099A (es) | 2008-09-11 | 2010-04-30 | Enanta Pharm Inc | Inhibidores macrocíclicos de serina proteasas de hepatitis c |
| EP2658858A4 (en) | 2010-12-30 | 2014-06-25 | Enanta Pharm Inc | MACROCYCLIC INHIBITORS OF HEPATITIS C SERINE PROTEASE PHENANTHRIDINE |
| MX2013007677A (es) | 2010-12-30 | 2013-07-30 | Abbvie Inc | Inhibidores macrociclicos de serina proteasa de hepatitis. |
| WO2012120532A2 (en) | 2011-02-02 | 2012-09-13 | Cadila Healthcare Limited | Cyclic short chain peptides |
| US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
| WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
| WO2024187241A1 (en) * | 2023-03-16 | 2024-09-19 | The Florey Institute Of Neuroscience And Mental Health | Stapled peptides |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1447600A (en) | 1998-10-22 | 2000-05-08 | Thomas J. Gardella | Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp) |
| AU7734800A (en) * | 1999-09-29 | 2001-04-30 | General Hospital Corporation, The | Polypeptide derivatives of parathyroid hormone (pth) |
| JP4723144B2 (ja) * | 1999-09-29 | 2011-07-13 | ザ ジェネラル ホスピタル コーポレイション | 副甲状腺ホルモン（ｐｔｈ）のポリペプチド誘導体 |
| CA2454275C (en) * | 2001-07-23 | 2012-10-23 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (pth) analogs |
| AU2002951372A0 (en) | 2002-09-13 | 2002-09-26 | St Vincent's Institute Of Medical Research | Parathyroid hormone-like polypeptides |
| JP4541899B2 (ja) | 2003-01-24 | 2010-09-08 | ザ ジェネラル ホスピタル コーポレイション | ラクタム架橋を有する、コンホメーションが制限された副甲状腺ホルモン（ｐｔｈ）アナログ |
| EP2201960A1 (en) * | 2003-03-19 | 2010-06-30 | The General Hospital Corporation | Conformationally constrained parathyroid hormones with alpha-helix stabilizers |
| JP4871128B2 (ja) | 2003-07-17 | 2012-02-08 | ザ ジェネラル ホスピタル コーポレイション | 高次構造的に制約された副甲状腺ホルモン（ｐｔｈ）アナログ |
| US20070123548A1 (en) | 2004-02-11 | 2007-05-31 | Cowan David J | Pth agonists |
| JP2007522214A (ja) | 2004-02-11 | 2007-08-09 | スミスクライン・ビーチャム・コーポレイション | Ｐｔｈアゴニスト |
| ITMI20041440A1 (it) | 2004-07-19 | 2004-10-19 | Abiogen Pharma Spa | Peptidi analoghi del pth-1-11 |
| CA2621264A1 (en) | 2005-09-06 | 2007-11-15 | Zelos Therapeutics, Inc. | Parathyroid hormone analogues and methods of use |
| EP1961765A1 (en) | 2006-12-08 | 2008-08-27 | Zealand Pharma A/S | Truncated PTH peptides with a cyclic conformation |
| MX353986B (es) * | 2007-08-01 | 2017-11-06 | Massachusetts Gen Hospital | Metodos de analisis y seleccion usando receptores acoplados a proteina g y composiciones relacionadas. |
-
2010
- 2010-04-26 EA EA201171292A patent/EA022212B1/ru not_active IP Right Cessation
- 2010-04-26 MX MX2011010968A patent/MX2011010968A/es active IP Right Grant
- 2010-04-26 EP EP10747683.0A patent/EP2421893A2/en not_active Withdrawn
- 2010-04-26 WO PCT/IN2010/000264 patent/WO2010128521A2/en not_active Ceased
- 2010-04-26 AU AU2010245642A patent/AU2010245642A1/en not_active Abandoned
- 2010-04-26 JP JP2012506651A patent/JP5744844B2/ja not_active Expired - Fee Related
- 2010-04-26 KR KR1020117026057A patent/KR101451470B1/ko not_active Expired - Fee Related
- 2010-04-26 CN CN2010800175792A patent/CN102405229A/zh active Pending
- 2010-04-26 BR BRPI1008103A patent/BRPI1008103A2/pt not_active IP Right Cessation
- 2010-04-26 SG SG2011068863A patent/SG174532A1/en unknown
- 2010-04-26 US US13/259,706 patent/US8383581B2/en not_active Expired - Fee Related
- 2010-04-26 CA CA2757874A patent/CA2757874C/en not_active Expired - Fee Related
- 2010-04-26 NZ NZ595437A patent/NZ595437A/en not_active IP Right Cessation
-
2011
- 2011-09-28 ZA ZA2011/07078A patent/ZA201107078B/en unknown
- 2011-10-09 IL IL215625A patent/IL215625A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010128521A3 (en) | 2011-03-10 |
| KR101451470B1 (ko) | 2014-10-15 |
| JP2012524775A (ja) | 2012-10-18 |
| CN102405229A (zh) | 2012-04-04 |
| US8383581B2 (en) | 2013-02-26 |
| IL215625A (en) | 2016-12-29 |
| WO2010128521A2 (en) | 2010-11-11 |
| EA022212B1 (ru) | 2015-11-30 |
| EA201171292A1 (ru) | 2012-05-30 |
| AU2010245642A1 (en) | 2011-10-27 |
| CA2757874C (en) | 2016-02-16 |
| KR20120034606A (ko) | 2012-04-12 |
| BRPI1008103A2 (pt) | 2016-05-03 |
| EP2421893A2 (en) | 2012-02-29 |
| MX2011010968A (es) | 2012-01-19 |
| IL215625A0 (en) | 2012-01-31 |
| JP5744844B2 (ja) | 2015-07-08 |
| SG174532A1 (en) | 2011-10-28 |
| CA2757874A1 (en) | 2010-11-11 |
| ZA201107078B (en) | 2014-03-26 |
| US20120108496A1 (en) | 2012-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ595437A (en) | Short-chain peptides as parathyroid hormone (pth) receptor agonist | |
| NZ600731A (en) | Oxyntomodulin peptide analogue | |
| NZ600732A (en) | Oxyntomodulin peptide analogue | |
| WO2009087082A3 (de) | Neue insulinderivate mit extrem verzögertem zeit- / wirkungsprofil | |
| MX2010004571A (es) | Composiciones y metodos que comprenden peptidos y proteasas de aminoacidos basicos. | |
| CL2013003416A1 (es) | Secuencia de peptidos quiméricos que comprende dsspl o dasph composiciones , usos y metodo para mejorar metabolismo de glucosa. | |
| MX2010001856A (es) | Proteina. | |
| NZ598356A (en) | Antigenic tau peptides and uses thereof | |
| IL192487A0 (en) | Non-natural amino acid polypeptides having modulated immunogenicity | |
| WO2009007714A3 (en) | Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour | |
| ES2575906T3 (es) | Composiciones y métodos de producir metionina | |
| AR093903A1 (es) | Coagonistas de glucagon y glp-1 para el tratamiento de la obesidad | |
| MX2018007955A (es) | Proceso de preparacion de agonistas c de guanilato cliclasa. | |
| NZ600363A (en) | Modified porcine somatotropin polypeptides and their uses | |
| IL220284A0 (en) | Insulin analogues with chlorinated amino acids, compositions comprising the same and uses thereof | |
| WO2013052946A3 (en) | Genetically encoded biosensors | |
| NZ600729A (en) | Fusion polypeptide against eb virus-induced tumor and colicin ia mutant | |
| AR120924A2 (es) | Método para el tratamiento de arroz | |
| NZ596036A (en) | Toll-like receptor 3 antagonists | |
| WO2007106792A3 (en) | Methods for treating sarcopenia with a growth hormone secretagogue | |
| GB201110815D0 (en) | Incorporation of subtituted lysines into polypeptides | |
| AR053259A1 (es) | Trigo con nuevo almidon y metodo para producirlo | |
| SG10201803541TA (en) | Biologically active c-terminal arginine-containing peptides | |
| WO2010057242A3 (de) | Vakzin | |
| EP2614075A4 (en) | UNILATED RELAXIN POLYPEPTIDES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 26 APR 2017 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20141018 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 APR 2018 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20170227 |
|
| LAPS | Patent lapsed |